top of page
dna-bkg3.jpg

Portfolio

Deciduous_Therapeutics___Finale_01_Logo_

Deciduous Therapeutics

Deciduous Therapeutics is developing novel immunotherapies that activate the body's immune system to target and eliminate pathogenic senescent cells, offering promising treatments for age-related diseases and overall improvements in health-span.

epibone.jpg

EpiBone

EpiBone, Inc. is a privately-held clinical-stage regenerative medicine company focused on skeletal reconstruction. Sitting at the intersection of biology and engineering, the company harnesses the power of cells to create living solutions that can become a seamless part of a patient’s body. EpiBone is currently developing a pipeline of bone, cartilage, and compound (bone and cartilage) products.

fauna_logo_clear.png

Fauna Bio

Fauna Bio is a first-of-its-kind biotech company that studies the protective genotypes across extreme biology to develop new therapies to improve human health and lifespan. Fauna Bio utilizes its drug discovery platform, Convergence™, to directly link extreme biological traits in mammals to human disease in a way that is scalable and high throughput. The company is currently pursuing initial discovery programs in various stages of development across pulmonary fibrosis, neuronal metabolism, obesity, and cardiac damage.

a02ae3_2cf48d3d53404053bbdaa77d53b80b4e~mv2.png

Marble Therapeutic

Marble Therapeutics is a biotechnology company with an overarching goal to pioneer real-world rejuvenation and enhancement products through a first-in-kind causal inference understanding of nonlinear dynamics in biology. Marble’s rejuvenation technologies are designed to solve barriers in dermatology, immuno-oncology, and broadly regenerative medicine.

RejuvenateBio.jpg

Rejuvenate Bio

Rejuvenate Bio is a spinout from the Wyss Institute at Harvard focused on reversing aging and eliminating age-related disease. Rejuvenate Bio utilizes gene therapy, proprietary targets, and tools to bring treatments to patients suffering from age-related conditions. The company is developing a pipeline of therapies with applications in cardiac and metabolic disease.

bottom of page